berberine has been researched along with Recrudescence in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Individuals aged 18-75 years who had at least one but no more than six histologically confirmed colorectal adenomas that had undergone complete polypectomy within the 6 months before recruitment were recruited and randomly assigned (1:1) to receive berberine (0·3 g twice daily) or placebo tablets via block randomisation (block size of six)." | 9.34 | Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. ( Cao, HL; Cao, XC; Chen, HM; Chen, YX; Dou, XT; Fang, JY; Gao, QY; Kang, Q; Li, N; Liu, SD; Liu, ZJ; Ren, JL; Sheng, JQ; Song, YY; Sun, XM; Wang, BM; Xiao, B; Xu, HZ; Yang, XN; Zhu, W; Zou, TH; Zou, XP, 2020) |
| "Colitis was induced by two cycles of 2." | 5.43 | Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses. ( Bian, ZX; Fatima, S; Hu, DD; Lee, NP; Li, YH; Lin, CY; Mu, HX; Xiao, HT, 2016) |
| " Individuals aged 18-75 years who had at least one but no more than six histologically confirmed colorectal adenomas that had undergone complete polypectomy within the 6 months before recruitment were recruited and randomly assigned (1:1) to receive berberine (0·3 g twice daily) or placebo tablets via block randomisation (block size of six)." | 5.34 | Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. ( Cao, HL; Cao, XC; Chen, HM; Chen, YX; Dou, XT; Fang, JY; Gao, QY; Kang, Q; Li, N; Liu, SD; Liu, ZJ; Ren, JL; Sheng, JQ; Song, YY; Sun, XM; Wang, BM; Xiao, B; Xu, HZ; Yang, XN; Zhu, W; Zou, TH; Zou, XP, 2020) |
| "Berberine gelatin treatment reduced the ulcer pain score compared with placebo gelatin (P < 0." | 2.78 | Effects of berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort. ( Jiang, XW; Li, FF; Lu, K; Peng, HY; Zhang, H; Zhang, Y; Zhu, YL, 2013) |
| "Colitis was induced by two cycles of 2." | 1.43 | Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses. ( Bian, ZX; Fatima, S; Hu, DD; Lee, NP; Li, YH; Lin, CY; Mu, HX; Xiao, HT, 2016) |
| "Berberine was administered through gavage to C57BL/6 mice with established CDI-induced intestinal injury and colitis." | 1.42 | Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. ( Liu, W; Lv, Z; Peng, G; Su, J; Xu, H, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YX | 1 |
| Gao, QY | 1 |
| Zou, TH | 1 |
| Wang, BM | 1 |
| Liu, SD | 1 |
| Sheng, JQ | 1 |
| Ren, JL | 1 |
| Zou, XP | 1 |
| Liu, ZJ | 1 |
| Song, YY | 1 |
| Xiao, B | 1 |
| Sun, XM | 1 |
| Dou, XT | 1 |
| Cao, HL | 1 |
| Yang, XN | 1 |
| Li, N | 1 |
| Kang, Q | 1 |
| Zhu, W | 1 |
| Xu, HZ | 1 |
| Chen, HM | 1 |
| Cao, XC | 1 |
| Fang, JY | 1 |
| Kwon, S | 1 |
| Chan, AT | 1 |
| Han, Q | 1 |
| Tang, HZ | 1 |
| Zou, M | 1 |
| Zhao, J | 1 |
| Wang, L | 1 |
| Bian, ZX | 2 |
| Li, YH | 2 |
| Lv, Z | 1 |
| Peng, G | 1 |
| Liu, W | 1 |
| Xu, H | 1 |
| Su, J | 1 |
| Xiao, HT | 1 |
| Hu, DD | 1 |
| Fatima, S | 1 |
| Lin, CY | 1 |
| Mu, HX | 1 |
| Lee, NP | 1 |
| Jiang, XW | 1 |
| Zhang, Y | 1 |
| Zhu, YL | 1 |
| Zhang, H | 1 |
| Lu, K | 1 |
| Li, FF | 1 |
| Peng, HY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-controlled, Multicenter, Prospective Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas[NCT02226185] | Phase 2/Phase 3 | 1,108 participants (Actual) | Interventional | 2014-11-30 | Completed | ||
| Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis: a Prospective Cohort Study[NCT04543643] | Phase 3 | 288 participants (Anticipated) | Interventional | 2021-11-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for berberine and Recrudescence
| Article | Year |
|---|---|
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Topics: Adenoma; Adolescent; Adult; Aftercare; Aged; Antineoplastic Agents, Phytogenic; Berberine; Chemoprev | 2020 |
Effects of berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort.
Topics: Administration, Topical; Adult; Berberine; Chi-Square Distribution; China; Double-Blind Method; Fema | 2013 |
4 other studies available for berberine and Recrudescence
| Article | Year |
|---|---|
Extracting the benefits of berberine for colorectal cancer.
Topics: Adenoma; Antineoplastic Agents, Phytogenic; Aspirin; Berberine; Cardiovascular Diseases; Case-Contro | 2020 |
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Cell Line, Tumor; Colitis, Ulcerative; Cytokines; Dext | 2020 |
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clos | 2015 |
Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Topics: Animals; Berberine; Cells, Cultured; Chronic Disease; Colitis; Colon; Dextran Sulfate; Disease Model | 2016 |